28 JUNE 2018
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
2018 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
For further information please contact:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.